Copyright
©2010 Baishideng Publishing Group Co.
World J Stem Cells. Aug 26, 2010; 2(4): 81-92
Published online Aug 26, 2010. doi: 10.4252/wjsc.v2.i4.81
Published online Aug 26, 2010. doi: 10.4252/wjsc.v2.i4.81
Source of MSCs | Isolation | Origin | Isolation efficacy | Frequency | Expansion potential | Immunephenotype | Differentiationa | Immuno-suppression | Senescence/genetic stability/safety | Ref. |
Cord blood | Ficoll gradient Lineage depletion | Fetal | At best 60% | Very rare, 1/108 MNC Inverse correlation with gestational age | Dependent on seeding density | SSEA-3, SSEA-4, TRA 1-60, TRA 1-82, Nanog | Osteogenic Chondrogenic Adipogenic-significantly reduced compared to adult MSC endothelial | Inhibition of T cell proliferation | Cells senescence Stable Karyotype Non tumorigenic | [20,32] and own unpublished data[49,61,93,95,96] |
Umbilical Cord (Wharton´s jelly) Including UC matrix stem cells, UC perivascular cells, UC stroma cells | Removal of vein and arteries Mechanical dissection, Collagenase + hyaluronidase digestion | Fetal | 100% | 10-50 × 103 /cm UC | High Expansion potential | 20% no HLA class I, nor class II SSEA-4, TRA 1-60 | Osteogenic Chondrogenic Adipogenic-significantly reduced compared to adult MSC Neurogenic Myogenic, cardiac endothelial | Inhibition of T cell proliferation | Late senescence Telomerase Stable karyotype Non-tumorigenic | Reviewed in [59,95,97] |
Amniotic Fluid | Centrifugation | Fetal | 21/23 samples | Frequency 3 CFU-f/mL AF range 1-6 0.9%-1.5% | Expansion significantly higher than for BM-MSCs doubling time 18 h | Lower expression of CD44 and CD105 compared to BM-MSCs 90% positive for Oct-4 | Osteogenic Adipogenic Chondrogenic Hepatogenic Neurogenic Myogenic, cardio | Inhibition of T cell proliferation | Longer telomeres than BM-MSCs Stable karyotype Non tumorigenic | [95,98] |
Placenta (Amnion, chorion and decidua basalis) | dissection digestion with collagenase and DNase, Percoll gradient | Fetal/maternal | 62.5%-100% | Expansion significantly higher than for BM-MSC | SSEA-4, TRA 1-60, TRA 1-81 | Osteogenic Chondrogenic Adipogenic-significantly reduced compared to adult MSC | Inhibition of T cell proliferation | Cells senescence Rarely chromosomal changes no transformation No toxicity when injecting 1x107MSC/kg | [26,50,99,100] | |
Amnion (contains besides MSCs amniotic epithelial cells) | Mechanical peeling, mincing Trypsin treatment, digestion with collagenase or/and DNase | Fetal | 4 × 106/100 cm2 starting material Or 1 × 106 /g of tissue | First trimester proliferate better than third trimester | SSEA-3, SSEA-4, Nanog | Adipogenic Chondrogenic Osteogenic Myogenic, skeletal Myogenic, cardio Angiogenic Neurogenic Pancreatic | Inhibition of T cell proliferation | Cells senescence Stable Karyotype Non tumorigenic | Reviewed in [21] [95,101,102] | |
Chorion (contains besides MSCs chorionic trophoblastic cells) | Mechanical removal, dispase and collagenase digestion | Fetal | Expansion significantly higher than for BM-MSC | Adipogenic Chondrogenic Osteogenic Myogenic, skeletal Neurogenic | Inhibition of T cell proliferation | Cells senescence Stable Karyotype Non tumorigenic | Reviewed in [21] |
- Citation: Bieback K, Brinkmann I. Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy. World J Stem Cells 2010; 2(4): 81-92
- URL: https://www.wjgnet.com/1948-0210/full/v2/i4/81.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v2.i4.81